US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 5.4000
  • +0.5600+11.57%
Close Jul 24 16:00 ET
  • 5.3000
  • -0.1000-1.85%
Post 18:17 ET
48.16MMarket Cap-8437P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.85%2.55M
-26.32%14.58M
-3.32%2.94M
-45.08%3.2M
-21.53%4.13M
-56.00%4.31M
-49.87%19.79M
-68.88%3.04M
-41.87%5.83M
-51.71%5.27M
Selling and administrative expenses
-43.80%1.22M
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-41.94%2.17M
-12.29%11.34M
-45.94%1.62M
-0.15%3.23M
-11.91%3.14M
-General and administrative expense
-43.80%1.22M
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-41.94%2.17M
-12.29%11.34M
-45.94%1.62M
-0.15%3.23M
-11.91%3.14M
Research and development costs
-23.74%2.58M
-12.96%10.42M
19.93%2.62M
-43.07%2.04M
-18.67%2.38M
-51.94%3.38M
-56.94%11.97M
-72.78%2.18M
-47.06%3.59M
-60.22%2.92M
Other operating expenses
-0.79%-1.24M
5.76%-3.31M
-39.17%-1.06M
74.23%-257.61K
3.52%-762.66K
-28.00%-1.23M
-182.96%-3.51M
---759.14K
---999.57K
---790.51K
Operating profit
40.85%-2.55M
26.32%-14.58M
3.32%-2.94M
45.08%-3.2M
21.53%-4.13M
56.00%-4.31M
49.87%-19.79M
68.88%-3.04M
41.87%-5.83M
51.71%-5.27M
Net non-operating interest income expense
84.51%156.2K
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
4,251.98%248.06K
11,191.02%109.41K
12,510.62%99.75K
1,389.22%35.79K
Non-operating interest income
84.51%156.2K
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
4,251.98%248.06K
11,191.02%109.41K
12,510.62%99.75K
1,389.22%35.79K
Other net income (expense)
90.32%-232.97K
-114.09K
Other non- operating income (expenses)
----
----
----
----
----
----
90.32%-232.97K
---114.09K
----
----
Income before tax
43.36%-2.39M
28.99%-14.04M
10.08%-2.74M
47.93%-2.98M
21.67%-4.1M
57.37%-4.22M
52.78%-19.78M
68.83%-3.04M
53.93%-5.73M
52.02%-5.23M
Income tax
3.68K
0
Net income
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
Net income continuous Operations
43.36%-2.39M
28.97%-14.05M
9.96%-2.74M
47.93%-2.98M
21.67%-4.1M
57.37%-4.22M
52.78%-19.78M
68.83%-3.04M
53.93%-5.73M
52.02%-5.23M
Net income discontinuous operations
--0
157.21%5.81M
92.26%-62.94K
--0
264.90%6.61M
---742.75K
---10.15M
---813.06K
---1.19M
---4.01M
Minority interest income
Net income attributable to the parent company
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
Basic earnings per share
52.63%-0.27
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
34.55%-3.58
61.54%-0.45
44.67%-0.83
14.62%-1.11
Diluted earnings per share
52.63%-0.27
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
34.55%-3.58
61.54%-0.45
44.67%-0.83
14.62%-1.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.85%2.55M-26.32%14.58M-3.32%2.94M-45.08%3.2M-21.53%4.13M-56.00%4.31M-49.87%19.79M-68.88%3.04M-41.87%5.83M-51.71%5.27M
Selling and administrative expenses -43.80%1.22M-34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-41.94%2.17M-12.29%11.34M-45.94%1.62M-0.15%3.23M-11.91%3.14M
-General and administrative expense -43.80%1.22M-34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-41.94%2.17M-12.29%11.34M-45.94%1.62M-0.15%3.23M-11.91%3.14M
Research and development costs -23.74%2.58M-12.96%10.42M19.93%2.62M-43.07%2.04M-18.67%2.38M-51.94%3.38M-56.94%11.97M-72.78%2.18M-47.06%3.59M-60.22%2.92M
Other operating expenses -0.79%-1.24M5.76%-3.31M-39.17%-1.06M74.23%-257.61K3.52%-762.66K-28.00%-1.23M-182.96%-3.51M---759.14K---999.57K---790.51K
Operating profit 40.85%-2.55M26.32%-14.58M3.32%-2.94M45.08%-3.2M21.53%-4.13M56.00%-4.31M49.87%-19.79M68.88%-3.04M41.87%-5.83M51.71%-5.27M
Net non-operating interest income expense 84.51%156.2K117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K4,251.98%248.06K11,191.02%109.41K12,510.62%99.75K1,389.22%35.79K
Non-operating interest income 84.51%156.2K117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K4,251.98%248.06K11,191.02%109.41K12,510.62%99.75K1,389.22%35.79K
Other net income (expense) 90.32%-232.97K-114.09K
Other non- operating income (expenses) ------------------------90.32%-232.97K---114.09K--------
Income before tax 43.36%-2.39M28.99%-14.04M10.08%-2.74M47.93%-2.98M21.67%-4.1M57.37%-4.22M52.78%-19.78M68.83%-3.04M53.93%-5.73M52.02%-5.23M
Income tax 3.68K0
Net income 51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M
Net income continuous Operations 43.36%-2.39M28.97%-14.05M9.96%-2.74M47.93%-2.98M21.67%-4.1M57.37%-4.22M52.78%-19.78M68.83%-3.04M53.93%-5.73M52.02%-5.23M
Net income discontinuous operations --0157.21%5.81M92.26%-62.94K--0264.90%6.61M---742.75K---10.15M---813.06K---1.19M---4.01M
Minority interest income
Net income attributable to the parent company 51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M
Basic earnings per share 52.63%-0.2773.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.5734.55%-3.5861.54%-0.4544.67%-0.8314.62%-1.11
Diluted earnings per share 52.63%-0.2773.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.5734.55%-3.5861.54%-0.4544.67%-0.8314.62%-1.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg